Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/brainsci13101464
PubMed Identifier: 37891832
Publication URI: http://europepmc.org/abstract/MED/37891832
Type: Journal Article/Review
Parent Publication: Brain Sciences
Issue: 10